Items Tagged ‘#diffuse large B cell lymphoma’
March 27, 2018
Putting the precision in precision medicine care for non-Hodgkin’s lymphoma
By Sharon Rosen 
Each year, more than 20,000 people in the U.S. are diagnosed with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma. While the likelihood of developing the disease increases with age, men and women in all age groups and from many ethnic backgrounds can develop the disease, which can start in many areas of […]
Tags: #blood test, #diffuse large B cell lymphoma, #Dr. Grzegorz Nowakowski, #Dr. Lisa Rimsza, #medical reearch, #Molecular Diagnostic Arizona Laboratory, #non-Hodgkin's lymphoma, center for individualized medicine, DNA, DNA Sequencing, genetic test, Genetics
December 21, 2016
Mayo Clinic first in U.S. to offer lymphoma genomic diagnostic test for patients
By Sharon Rosen
Article by Colette Gallagher, Public Affairs More than 20,000 people in the U.S. are diagnosed with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma each year. Mayo Clinic is the first site in the country to offer a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell […]
Tags: #diffuse large B cell lymphoma, #Lymph2Cx test, #Mayo Clinic Molecular Diagnostic Arizona Laboratory, #non-Hodgkin's lymphoma, center for individualized medicine, lymphoma, mayo clinic, medical research, Precision Medicine